Qinghua Wang – CEO & Founder, Innogen, China
The rate of diabetes in China has exploded: the number of diabetic patients has surpassed 100 million and is…
Mr Wu Yifang joined Chinese company Fosun Pharma in April 2004 and now serves as their President and Chief Executive Officer.
Mr Wu was Vice President and Chief Operation Director of Fosun Pharma from July 2014 to January 2016 and has been President and Chief Executive Officer of Fosun Pharma since June 2016, as well as Executive Director since August 2016.
Mr Wu used to serve as a Technician, Director, Production Officer, Finance Director, Assistant to Director of Xuzhou Biochemical Pharmaceutical Factory, now known as Wanbang Pharma.
Mr Wu graduated from Nanjing University of Science and Technology majoring in international commerce in 1996 and obtained a master degree in business administration (pharmaceutical marketing) from Saint Joseph’s University in 2005.
The rate of diabetes in China has exploded: the number of diabetic patients has surpassed 100 million and is…
Dr Dong Wei, CEO of EdiGene, shares the fascinating story behind the establishment of EdiGene, including his close…
Speaking in May 2019, Dr Dajun Yang, chairman, executive director and CEO of Ascentage Pharma, shares the…
Mark Lotter, founder and CEO of Nuance Biotech, explains why he decided to return to the China market to establish…
PharmaBoardroom recently analysed the contents of 10 interviews conducted with country managers at multinational…
Dr. Zhang Yu, CEO of Aeon Therapeutics, shares the unique journey that motivated him to establish Aeon…